Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858)
14.61
-0.20 (-1.35%)
Sep 6, 2024, 3:00 PM CST
Shandong Buchang Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -195.75 | 318.97 | -1,530 | 1,289 | 1,861 | 1,946 | Upgrade
|
Depreciation & Amortization | 358.49 | 426.56 | 497.56 | 510.43 | 424.55 | 386.08 | Upgrade
|
Other Amortization | 311.22 | 230.72 | 38.19 | 3.48 | 2.03 | 3.07 | Upgrade
|
Loss (Gain) From Sale of Assets | -1.55 | -1.53 | -0.77 | -1.68 | -1.13 | -0.13 | Upgrade
|
Asset Writedown & Restructuring Costs | 602.65 | 602.34 | 2,944 | 12.42 | 1.91 | 3.56 | Upgrade
|
Loss (Gain) From Sale of Investments | 1.34 | -18.94 | 54.06 | 42.39 | -15.62 | -58.76 | Upgrade
|
Provision & Write-off of Bad Debts | -12.31 | 7.98 | 4.41 | 15.12 | 1.45 | -22.46 | Upgrade
|
Other Operating Activities | 26.13 | -22.19 | 72.17 | 100.81 | 107.6 | 127.93 | Upgrade
|
Change in Accounts Receivable | 765.25 | 83.68 | 483.36 | 363.14 | -648.66 | 640.33 | Upgrade
|
Change in Inventory | -881.8 | -1,186 | 39.52 | -1,066 | -847.77 | -537.91 | Upgrade
|
Change in Accounts Payable | -841.01 | -493.59 | 172.01 | 92.54 | 1,058 | 209.78 | Upgrade
|
Operating Cash Flow | 33.73 | -195.61 | 2,756 | 1,321 | 1,959 | 2,621 | Upgrade
|
Operating Cash Flow Growth | -97.89% | - | 108.68% | -32.58% | -25.28% | 27.82% | Upgrade
|
Capital Expenditures | -414.79 | -529.92 | -543.17 | -433.53 | -536.44 | -662.11 | Upgrade
|
Sale of Property, Plant & Equipment | 2.21 | 2.4 | 0.48 | 1.45 | 10.23 | 0.52 | Upgrade
|
Cash Acquisitions | - | 0.75 | - | -272.7 | 66.43 | -20.27 | Upgrade
|
Divestitures | -0 | -0.2 | - | -0.04 | 21.66 | - | Upgrade
|
Investment in Securities | 44.62 | 328.37 | -478.96 | -46.91 | -28.51 | -11.93 | Upgrade
|
Other Investing Activities | 12.66 | 30.6 | 11.47 | 96.05 | 44.91 | -576.4 | Upgrade
|
Investing Cash Flow | -355.29 | -168 | -1,010 | -655.67 | -421.72 | -1,270 | Upgrade
|
Long-Term Debt Issued | - | 1,505 | 2,295 | 3,173 | 3,079 | 2,269 | Upgrade
|
Total Debt Issued | 1,981 | 1,505 | 2,295 | 3,173 | 3,079 | 2,269 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | - | -0.57 | Upgrade
|
Long-Term Debt Repaid | - | -1,355 | -2,722 | -3,154 | -2,438 | -1,794 | Upgrade
|
Total Debt Repaid | -1,295 | -1,355 | -2,722 | -3,154 | -2,438 | -1,795 | Upgrade
|
Net Debt Issued (Repaid) | 685.51 | 150.1 | -426.96 | 18.9 | 641.75 | 474.83 | Upgrade
|
Repurchase of Common Stock | -432.37 | -9.99 | - | - | - | -740 | Upgrade
|
Common Dividends Paid | -1,207 | -1,194 | -547.34 | -746.21 | -2,488 | -920.58 | Upgrade
|
Other Financing Activities | 59.7 | -11.24 | -13.27 | -43.57 | -39.5 | -39.86 | Upgrade
|
Financing Cash Flow | -894.07 | -1,065 | -987.57 | -770.88 | -1,886 | -1,226 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.01 | 0.01 | 0.16 | -0.34 | -0.01 | 0 | Upgrade
|
Net Cash Flow | -1,216 | -1,429 | 758.04 | -106.38 | -348.95 | 125.54 | Upgrade
|
Free Cash Flow | -381.06 | -725.52 | 2,212 | 886.98 | 1,422 | 1,959 | Upgrade
|
Free Cash Flow Growth | - | - | 149.44% | -37.64% | -27.40% | 164.40% | Upgrade
|
Free Cash Flow Margin | -3.25% | -5.48% | 14.80% | 5.63% | 8.89% | 13.74% | Upgrade
|
Free Cash Flow Per Share | -0.35 | -0.66 | 2.00 | 0.80 | 1.29 | 1.76 | Upgrade
|
Cash Interest Paid | - | - | 5.02 | - | - | - | Upgrade
|
Cash Income Tax Paid | 1,416 | 1,819 | 1,915 | 2,308 | 2,116 | 2,460 | Upgrade
|
Levered Free Cash Flow | -896.85 | -558.66 | 1,955 | 915.43 | 869.9 | 1,519 | Upgrade
|
Unlevered Free Cash Flow | -821.89 | -489.95 | 2,040 | 1,020 | 960.56 | 1,604 | Upgrade
|
Change in Net Working Capital | 1,447 | 1,265 | -937.07 | 148.37 | 358.85 | -454.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.